VEGFA and cancer: Anti-vascular endothelial growth factor monoclonal antibody (anti-VEGF) or immune checkpoint inhibitors (ICIs) combined with chemotherapy have been approved for advanced cancer because of their substantial improvements in survival compared with chemotherapy alone [1–6].